How to Overcome Addiction to Substances or Behaviors | Dr. Keith Humphreys

Summary

This Huberman Lab episode has Andrew Huberman interview psychiatrist and addiction-policy researcher Keith Humphreys about addiction risk, commercial incentives, recovery, treatment, and regulation across alcohol, cannabis, gambling, stimulants, nicotine, opioids, digital media, and other behaviors. Humphreys defines addiction through persistent harmful behavior and progressive life narrowing, then connects Addiction-Related Reward Plasticity and Addiction as Attempted Relief to practical cue control, immediate incentives, social accountability, evidence-based care, and multiple recovery pathways. The episode’s distinctive policy contribution is Addiction for Profit, which treats dependence-producing customers, product design, advertising, potency, availability, and lobbying as population-level risk factors rather than neutral market conditions.

Key Claims

• Addiction is more specific than frequent use: persistent behavior despite harm, loss of control, and progressive narrowing of ordinary rewards distinguish severe addiction from a broader spectrum of use disorder.
• Genetic liability, age of first exposure, product potency and route, social context, commercial availability, and alternative rewards interact; family history is useful risk information but not destiny.
• Addiction is deeply learned: cues can activate reward circuitry and predict relapse even when a person sincerely reports low craving or wants recovery.
• Substances and behaviors often serve functions such as relief, escape, social ritual, or oblivion, so recovery may involve grief and requires replacing what use provided rather than only removing it.
• Recovery can proceed through clinical treatment, medication where evidence supports it, contingency management, mutual-help groups, recovery housing, family or court leverage, environmental friction, and ordinary life changes; no single pathway fits every person.
• AA and twelve-step facilitation are presented as unusually accessible and well supported for alcohol abstinence, while evidence for other drugs is encouraging but less mature and individual meetings vary enough to justify trying several.
• Industries selling alcohol, cannabis, gambling, nicotine, or frictionless digital engagement can profit disproportionately from heavy or dependent users, supporting advertising limits, taxes, access friction, and other public-health controls.

Key Quotes

The supplied episode document is a structured summary rather than a verbatim transcript, so no direct quotations are retained.

Connections

• Keith Humphreys - guest and principal source voice on addiction science, treatment systems, recovery, and policy.
• Andrew Huberman and Huberman Lab - host and show context for the long-form interview.
• Addiction-Related Reward Plasticity - durable learning and cue-triggered relapse that may exceed conscious craving reports.
• Addiction as Attempted Relief - substances and behaviors as functional escape, relief, or social ritual whose loss can produce grief.
• Recovery Community Connection - mutual help, varied meeting fit, accountability, immediate access, and one-day-at-a-time action.
• Addiction for Profit - commercial dependence on heavy use and product or marketing systems that amplify exposure.
• Cannabis Dose-Route-Vulnerability Framework and Cannabis-Psychosis Causality Boundary - potency, edible redosing, developmental exposure, and family-history caution.
• Gambling Friction Regulation and Machine Gambling Addiction - advertising exposure, continuous play, reinforcement design, and losses disguised as wins.
• Pleasure-Pain Balance in Addiction - withdrawal relief that can be misread as a continuing benefit of nicotine, cannabis, or opioids.
• Psychedelic Clinical Supervision Boundary - promise, hype, abuse potential, adverse experiences, and the need for controlled evidence.

Contradictions

• No settled contradiction is adopted. Humphreys rejects reliable self-titration as a general answer to high-potency cannabis, qualifying the partial self-titration evidence summarized in Cannabis Dose-Route-Vulnerability Framework without proving that compensation never occurs.
• The episode presents cannabis-psychosis concern more strongly as potency and frequency rise, while the wiki retains Cannabis-Psychosis Causality Boundary because association, triggering, shared vulnerability, and independent causation remain distinct claims.
• The Cochrane characterization of AA, stimulant contingency-management evidence, GLP-1 addiction signals, TMS and implant cases, Medicaid and parity effects, civil commitment, drug-court leverage, and recovery-housing outcomes remain source-scoped until study designs and implementation contexts are reviewed directly.
• Potency, prevalence, sex-ratio, industry-share, health-risk, homelessness, treatment-access, and policy figures are episode-level claims rather than universal estimates or individualized medical guidance.
• Abrupt withdrawal, severe addiction, suicidality, psychosis, intoxication, and unsafe housing require qualified assessment or emergency care; the episode does not provide a self-treatment protocol.